The initiative also focuses on how devices will be regulated in the post-market world.
U.S. companies will be able to showcase their technological advancements.
Are digital technologies actually getting in the way of effectively treating patients?
The collaboration has resulted in a solution that aims to improve patient outcomes and reduce costs.
Managing data, interoperability and cybersecurity issues were at the top of the list for industry stakeholders.
Leveraging big data and clinical evidence is top of mind.
As the agency continues to try to do more with fewer resources, taking additional risks is imperative to move forward.